Emergency Medicine Pulmonary Embolism Testing Multicentre Study: Lung Diseases and Conditions – Pulmonary Embolism

2024 APR 01 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Hematology Daily -- Staff editors report on the newly launched clinical trial, NCT06320236, which has the following summary description: “It is important to diagnose pulmonary embolism in a timely manner to prevent death and long-term disability. More than half a million people (4-5% of emergency department patients) are tested for pulmonary embolism, although positive results are low. Imaging for PE testing exposes patients to radiation, is expensive, adds time to the emergency visit, and can lead to a false positive diagnoses. Existing protocols aimed at reducing unnecessary pulmonary embolism imaging are complex and seldom used by emergency physicians. Too many patients undergo unnecessary pulmonary embolism imaging. We have created a new tool (called Adjust-Unlikely) which could safely reduce pulmonary embolism imaging in Canada. Our research group composed of researchers, emergency physicians, and patients developed the Adjust-Unlikely clinical decision rule: a rule which has been customized for emergency physicians and emergency patients. Adjust-Unlikely is highly sensitive at the bedside, meaning there are very few false negative results. Our study aim is to prospectively validate Adjust-Unlikely pulmonary embolism testing in emergency patients with suspected pulmonary embolism.”

As a matter of record, on March 21, 2024, NewsRx staff editors report that the available information provided by Queen’s University on this trial include:

Tracking Information

Descriptive Information

Recruitment Information

Administrative Information

(Our reports deliver fact-based news of research and discoveries from around the world.)